His primary scientific interests are in Immunology, Allergy, Asthma, Dermatology and Family medicine. Immunology is often connected to Global health in his work. His work deals with themes such as Guideline, Randomized controlled trial, Pediatrics, Triamcinolone acetonide and Ebastine, which intersect with Allergy.
The various areas that P. Van Cauwenberge examines in his Asthma study include Non-allergic rhinitis, Epidemiology, Evidence-based medicine and Disease. His Dermatology study combines topics from a wide range of disciplines, such as Allergic sensitization, Allergen, Hay fever and Sensitization. His Nonallergic rhinitis research is multidisciplinary, incorporating elements of Allergen immunotherapy, Bilastine, Azelastine, Food allergy and Prevalence.
P. Van Cauwenberge focuses on Immunology, Allergy, Asthma, Surgery and Pathology. Immunoglobulin E, Immune system, Inflammation, Nasal polyps and Sinusitis are among the areas of Immunology where P. Van Cauwenberge concentrates his study. His research integrates issues of Dermatology, Internal medicine, Immunopathology and Antihistamine in his study of Allergy.
His Asthma course of study focuses on Disease and Intensive care medicine. Surgery is a component of his Endoscopy, Otorhinolaryngology and Complication studies. His Pathology study incorporates themes from Wound healing and Matrix metalloproteinase.
P. Van Cauwenberge spends much of his time researching Profitability index, Immunology, Flemish, Accounting and European union. His Profitability index research includes themes of Insider trading and Urbanization. His work is connected to Allergy and Asthma, as a part of Immunology.
The concepts of his Allergy study are interwoven with issues in Family medicine, Immunoglobulin E and T cell, Superantigen. The study incorporates disciplines such as Panel data and Entrepreneurship in addition to Flemish. The Generally Accepted Auditing Standards, International Financial Reporting Standards and Financial accounting research P. Van Cauwenberge does as part of his general Accounting study is frequently linked to other disciplines of science, such as General government sector and Private sector, therefore creating a link between diverse domains of science.
His primary areas of study are Immunology, Asthma, Allergy, European union and Global health. P. Van Cauwenberge is interested in Respiratory virus, which is a field of Immunology. His studies examine the connections between Asthma and genetics, as well as such issues in Pathology, with regards to Health care quality and Nonallergic rhinitis.
He combines subjects such as Immunoglobulin E and T cell, Superantigen with his study of Allergy. In general Immunoglobulin E study, his work on Allergic sensitization often relates to the realm of Peripheral blood mononuclear cell, thereby connecting several areas of interest. His Global health research integrates issues from Identification and Systems medicine, Systems biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly.
The Journal of Allergy and Clinical Immunology (2012)
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
J. Bousquet;N. Khaltaev;A. A. Cruz;J. Denburg.
Allergy (2008)
A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force.
S. G. O. Johansson;J.O'b Hourihane;J. Bousquet;C. Bruijnzeel‐Koomen.
Allergy (2001)
Allergenic pollen and pollen allergy in Europe
G D'Amato;L Cecchi;S Bonini;S Bonini;C Nunes.
Allergy (2007)
Consensus statement * on the treatment of allergic rhinitis
P van Cauwenberge;C Bachert;G Passalacqua;J Bousquet.
Allergy (2000)
Differentiation of chronic sinus diseases by measurement of inflammatory mediators.
T. Van Zele;S. Claeys;P. Gevaert;G. Van Maele.
Allergy (2006)
Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7-10 December 1999, Geneva, Switzerland.
J. Bousquet;P. Van Cauwenberge;N. Khaltaev.
Allergy (2002)
Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper
Mk K. Church;Mk K. Church;M. Maurer;Fer E. R. Simons;C. Bindslev-Jensen.
Allergy (2010)
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review.
N G Papadopoulos;I Christodoulou;G Rohde;I Agache.
Allergy (2011)
Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium
C. Bachert;P. Van Cauwenberge;J. Olbrecht;J. Van Schoor.
Allergy (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Ghent University
Inserm : Institut national de la santé et de la recherche médicale
Ghent University
Istituto di Farmacologia Traslazionale
Ghent University
University of Helsinki
University College London
National Institutes of Health
University of Amsterdam
Humanitas University
University of Ottawa
University College London
University of St Andrews
Tokyo Institute of Technology
Swedish University of Agricultural Sciences
University of Wyoming
Imperial College London
Columbia University
Kansai Medical University
University of St Andrews
Universität Hamburg
University of Adelaide
Boston University
Rush University Medical Center
University of Western Ontario
Victoria University of Wellington